T4

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2015-05-28 for T4 manufactured by Roche Diagnostics.

Event Text Entries

[13477884] The 3 patient samples were submitted for investigation. The investigation confirmed the presence of a streptavidin interfering factor. This specific interference is addressed in product labeling.
Patient Sequence No: 1, Text Type: N, H10


[13491044] Clarification was received that the "s-trak" results are results for antibodies to tsh receptor (anti-tshr). The results for each patient were obtained from the same sample. Clarification was received that the erroneous results were reported outside of the laboratory where the physicians did not agree with the results. Clarification was received that none of the patients were adversely affected.
Patient Sequence No: 1, Text Type: N, H10


[19985598] The customer complained of erroneous high "s-trak" results for 3 patient samples when compared between the cobas system and a brahms kryptor compact system. The "s-trak" results are believed to be results for antibodies to tsh receptor (anti-tshr). The values were normal for all 3 patients on the brahms kryptor compact system which matched the clinical picture for each patient. The customer noted that, for these 3 patients, other thyroid tests also ran higher on the cobas system when compared to other analyzers. Based on the data provided erroneous thyrotropin (tsh), free thyroxine (ft4), thyroxine (t4), free triiodothyronine (ft3), and triiodothyronine (t3) were identified. It is not known if erroneous results were reported outside of the laboratory. This information was requested. The date of event for each patient is not known. Please see the attachment to the medwatch for test results and patient demographics. This medwatch will cover t4. Refer to medwatch with patient identifier (b)(6) for information on the anti-tshr erroneous results. Refer to medwatch with patient identifier (b)(6) for information on the tsh erroneous results. Refer to medwatch with patient identifier (b)(6) for information on the ft4 erroneous results. Refer to medwatch with patient identifier (b)(6) for information on the ft3 erroneous results. Refer to medwatch with patient identifier (b)(6) for information on the t3 erroneous results. No adverse events reported. The cobas e602 analyzer serial number was not provided.
Patient Sequence No: 1, Text Type: D, B5


[20431936] This event occurred in (b)(6). Patient was born in 1950. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2015-03536
MDR Report Key4802578
Report Source01,05,06
Date Received2015-05-28
Date of Report2015-06-23
Date of Event2015-05-03
Date Mfgr Received2015-05-03
Date Added to Maude2015-05-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameT4
Generic NameRADIOIMMUNOASSAY, TOTAL THYROXINE
Product CodeCDX
Date Received2015-05-28
Model NumberNA
Catalog NumberASKU
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2015-05-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.